Emtricitabine/Tenofovir Disoproxil Biogaran

Emtricitabine/Tenofovir Disoproxil Biogaran is a combination medication used for HIV treatment and prevention. This oral antiretroviral therapy helps manage HIV infection and reduce transmission risk.

Emtricitabine/Tenofovir Disoproxil Biogaran is primarily used in the treatment of HIV-1 infection in adults and adolescents. It is also used for pre-exposure prophylaxis (PrEP) to prevent HIV infection in individuals at high risk. This medication works by reducing the amount of HIV in the body, helping to improve immune function and lower the risk of HIV transmission.

Common effects of Emtricitabine/Tenofovir Disoproxil Biogaran may include headache, nausea, diarrhea, and fatigue. Some individuals may experience dizziness or rash. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Emtricitabine/Tenofovir Disoproxil Biogaran should be handled with care, especially by individuals with kidney problems or bone disorders. Regular monitoring of kidney function and bone density is recommended. This medication should be stored at room temperature and kept out of reach of children.

Emtricitabine/Tenofovir Disoproxil Biogaran may interact with other medications, including certain antibiotics, antifungals, and anticonvulsants. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.